vs

Side-by-side financial comparison of BOSTON OMAHA Corp (BOC) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $29.7M, roughly 1.3× BOSTON OMAHA Corp). On growth, BOSTON OMAHA Corp posted the faster year-over-year revenue change (6.4% vs -57.1%). Over the past eight quarters, BOSTON OMAHA Corp's revenue compounded faster (7.8% CAGR vs -46.5%).

Boston Omaha Corporation is a publicly traded diversified holding company. Its core operating segments include outdoor advertising, surety insurance, residential real estate development, and fixed wireless broadband services, primarily serving customers across the United States, with a focus on driving long-term shareholder value via strategic acquisitions and organic operational growth.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

BOC vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.3× larger
ORGO
$37.2M
$29.7M
BOC
Growing faster (revenue YoY)
BOC
BOC
+63.4% gap
BOC
6.4%
-57.1%
ORGO
Faster 2-yr revenue CAGR
BOC
BOC
Annualised
BOC
7.8%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BOC
BOC
ORGO
ORGO
Revenue
$29.7M
$37.2M
Net Profit
$-6.9M
Gross Margin
64.0%
30.8%
Operating Margin
-4.2%
-185.1%
Net Margin
-23.1%
Revenue YoY
6.4%
-57.1%
Net Profit YoY
-228.1%
EPS (diluted)
$-0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BOC
BOC
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$29.7M
$225.6M
Q3 25
$28.7M
$150.9M
Q2 25
$28.2M
$101.0M
Q1 25
$27.7M
$86.7M
Q4 24
$27.9M
$126.7M
Q3 24
$27.7M
$115.2M
Q2 24
$27.1M
$130.2M
Net Profit
BOC
BOC
ORGO
ORGO
Q1 26
Q4 25
$-6.9M
$43.7M
Q3 25
$-2.6M
$21.6M
Q2 25
$-2.3M
$-9.4M
Q1 25
$-669.3K
$-18.8M
Q4 24
$5.3M
$7.7M
Q3 24
$-1.6M
$12.3M
Q2 24
$-2.2M
$-17.0M
Gross Margin
BOC
BOC
ORGO
ORGO
Q1 26
30.8%
Q4 25
64.0%
Q3 25
66.2%
Q2 25
66.1%
Q1 25
67.3%
72.6%
Q4 24
69.5%
75.5%
Q3 24
67.5%
76.7%
Q2 24
68.2%
77.6%
Operating Margin
BOC
BOC
ORGO
ORGO
Q1 26
-185.1%
Q4 25
-4.2%
28.1%
Q3 25
-3.7%
13.7%
Q2 25
-2.9%
-12.5%
Q1 25
-2.9%
-30.9%
Q4 24
-4.6%
8.1%
Q3 24
-2.7%
5.4%
Q2 24
-16.2%
-10.7%
Net Margin
BOC
BOC
ORGO
ORGO
Q1 26
Q4 25
-23.1%
19.4%
Q3 25
-9.0%
14.3%
Q2 25
-8.2%
-9.3%
Q1 25
-2.4%
-21.7%
Q4 24
19.1%
6.1%
Q3 24
-5.8%
10.7%
Q2 24
-8.3%
-13.1%
EPS (diluted)
BOC
BOC
ORGO
ORGO
Q1 26
Q4 25
$-0.23
$0.31
Q3 25
$-0.08
$0.11
Q2 25
$-0.07
$-0.10
Q1 25
$-0.02
$-0.17
Q4 24
$0.17
$0.05
Q3 24
$-0.05
$0.09
Q2 24
$-0.07
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BOC
BOC
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$56.8M
$91.4M
Total DebtLower is stronger
$25.7M
Stockholders' EquityBook value
$516.1M
Total Assets
$713.1M
$520.0M
Debt / EquityLower = less leverage
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BOC
BOC
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$56.8M
$93.7M
Q3 25
$67.6M
$63.7M
Q2 25
$68.6M
$73.1M
Q1 25
$69.2M
$110.0M
Q4 24
$73.2M
$135.6M
Q3 24
$58.6M
$94.3M
Q2 24
$53.1M
$89.9M
Total Debt
BOC
BOC
ORGO
ORGO
Q1 26
Q4 25
$25.7M
Q3 25
$25.9M
Q2 25
$26.1M
Q1 25
$26.3M
Q4 24
$26.5M
Q3 24
$26.7M
$62.3M
Q2 24
$26.9M
$63.8M
Stockholders' Equity
BOC
BOC
ORGO
ORGO
Q1 26
Q4 25
$516.1M
$300.1M
Q3 25
$528.4M
$255.1M
Q2 25
$531.0M
$233.2M
Q1 25
$533.3M
$242.9M
Q4 24
$532.8M
$262.9M
Q3 24
$527.7M
$278.5M
Q2 24
$530.5M
$263.5M
Total Assets
BOC
BOC
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$713.1M
$598.7M
Q3 25
$721.4M
$509.8M
Q2 25
$730.6M
$461.1M
Q1 25
$730.8M
$467.4M
Q4 24
$728.3M
$497.9M
Q3 24
$711.9M
$446.3M
Q2 24
$723.1M
$443.2M
Debt / Equity
BOC
BOC
ORGO
ORGO
Q1 26
Q4 25
0.05×
Q3 25
0.05×
Q2 25
0.05×
Q1 25
0.05×
Q4 24
0.05×
Q3 24
0.05×
0.22×
Q2 24
0.05×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BOC
BOC
ORGO
ORGO
Operating Cash FlowLast quarter
$17.9M
Free Cash FlowOCF − Capex
$-10.0M
FCF MarginFCF / Revenue
-33.8%
Capex IntensityCapex / Revenue
93.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-17.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BOC
BOC
ORGO
ORGO
Q1 26
Q4 25
$17.9M
$39.4M
Q3 25
$4.9M
$3.1M
Q2 25
$4.6M
$-32.9M
Q1 25
$2.6M
$-19.9M
Q4 24
$21.2M
$10.9M
Q3 24
$5.2M
$8.7M
Q2 24
$4.5M
$4.7M
Free Cash Flow
BOC
BOC
ORGO
ORGO
Q1 26
Q4 25
$-10.0M
$34.8M
Q3 25
$-489.4K
$844.0K
Q2 25
$-2.7M
$-36.5M
Q1 25
$-4.3M
$-23.6M
Q4 24
$-11.0M
$7.6M
Q3 24
$-1.2M
$6.1M
Q2 24
$-4.3M
$2.9M
FCF Margin
BOC
BOC
ORGO
ORGO
Q1 26
Q4 25
-33.8%
15.4%
Q3 25
-1.7%
0.6%
Q2 25
-9.7%
-36.1%
Q1 25
-15.5%
-27.2%
Q4 24
-39.2%
6.0%
Q3 24
-4.4%
5.3%
Q2 24
-15.9%
2.2%
Capex Intensity
BOC
BOC
ORGO
ORGO
Q1 26
Q4 25
93.9%
2.1%
Q3 25
18.9%
1.5%
Q2 25
25.9%
3.6%
Q1 25
24.7%
4.2%
Q4 24
115.3%
2.7%
Q3 24
23.2%
2.2%
Q2 24
32.6%
1.4%
Cash Conversion
BOC
BOC
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
3.97×
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BOC
BOC

Billboard Rentals$11.9M40%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$10.0M34%
GIG$7.3M25%
Other$608.4K2%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons